Vol 58, No 3 (2024)
Letter to the Editors
Published online: 2024-04-02
Migraine in the elderly — diagnosis and treatment: a single-centre experience
1
Abstract
Not available
Keywords: elderlyepidemiologygeneral practitionermigraineolder adults
References
- GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545–1602.
- Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017; 372: 307–315.
- Lipton RB, Steward WF. Migraine in the United States: a review of epidemiology and health care use. Neurology. 1993; 43: S6–10.
- Buse DC, Fanning KM, Reed ML, et al. Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019; 59(8): 1286–1299.
- Stovner Lj, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193–210.
- Riggins N, Ehrlich A. Episodic Migraine and Older Adults. Curr Pain Headache Rep. 2022; 26(4): 331–335.
- Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001; 41(7): 646–657.
- Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008; 7(4): 354–361.
- Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021; 397(10283): 1485–1495.
- Dees B, Coleman-Jackson R, Hershey LA. Managing migraine and other headache syndromes in those over 50. Maturitas. 2013; 76(3): 243–246.
- Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980; 7(1): 9–17.
- Young WB. A knockout punch: C. Miller Fisher's migraine accompaniments. Headache. 2008; 48(5): 726–727.
- Ramadan NM, Levine SR, Welch KM. Cerebral blood flow in migraine accompaniments and vertebrobasilar ischemia. Stroke. 1994; 25(6): 1219–1222.
- Ferbert A, Brückmann H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke. 1990; 21(8): 1135–1142.
- Hershey LA, Bednarczyk EM. Treatment of headache in the elderly. Curr Treat Options Neurol. 2013; 15(1): 56–62.
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629–808.
- Soni PP, Lee M, Shadbehr N, et al. Recent Advances in the Management of Migraine in Older Patients. Drugs Aging. 2020; 37(7): 463–468.
- Gonzalez-Martinez A, Sanz-García A, García-Azorín D, et al. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study. Pain Med. 2024; 25(3): 194–202.
- Muñoz-Vendrell A, Campoy S, Caronna E, et al. Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients. J Headache Pain. 2023; 24(1): 63.
- Katsuki M, Kashiwagi K, Kawamura S, et al. Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old. Cureus. 2023; 15(1): e34052.
